TransUnion TRU had an impressive run in the past six months. The company’s shares have gained 26.8% compared with its industry and the Zacks S&P 500 composite’s growth of 14% and 11.2%, respectively.
Image Source: Zacks Investment Research
TRU’s revenues are expected to rise 8.8% year over year in 2024 and 7.9% in 2025. Its earnings are estimated to increase 16% in 2024 and 16.9% in 2025.
TRU delivered a decent earnings surprise in the trailing four quarters. The company delivered a trailing four-quarter average earnings surprise of 7.3%, which outpaced the Zacks Consensus Estimate.
Ten estimates for 2024 have moved north in the past 60 days against no southward revision, reflecting analysts’ confidence in the company. The Zacks Consensus Estimate for 2024 earnings has increased from $3.88 per share to $3.91 in the same time.
The continuous growth in the insurance segment over the past few quarters is driven by a strong market trend. Insurers continue to increase marketing activity as rate adequacy enhances, driving demand for TRU’s credit-based marketing solutions and its suite of identity-based data hygiene, analytics solutions and audience.
The United States continues to witness solid economic and lending conditions. The finances of households remain healthy as a result of low unemployment and an increase in real wages, even though lower-income customers face affordability pressures from higher shelter, transportation, and other expenses. Consumer delinquencies have lowered for personal loans and seem to be stabilizing for credit cards and auto loans. Overall, such an environment promotes TransUnion’s financial services revenue growth.
The company witnessed a slight decline in this segment in the second quarter of 2024, while it recorded a 21% exponential rise in the third quarter. The recent breach remediation wins have driven this segment's growth. TransUnion’s cross-functional teams executed these contracts well, helping consumers and building its credibility in this space. This segment benefits from a broadened value proposition and go-to-market strategy in direct-to-consumer.
For 2024, TransUnion hiked its guided range for revenues to $4.16-$4.18 billion from the preceding quarter’s view of $4.10-$4.14 billion. The midpoint ($4.17 billion) of the company’s revised revenue guidance is in line with the Zacks Consensus Estimate. TRU raised its adjusted earnings per share outlook to $3.87-$3.93 from $3.78-$3.90 in the preceding quarter. The midpoint ($3.90) of the company’s new guided range is marginally higher than the Zacks Consensus Estimate for earnings of $3.89 per share. Adjusted EBITDA is now expected to be in the range of $1.48-$1.5 billion compared with $1.46-$1.49 billion anticipated in the previous quarter.
TRU carries a Zacks Rank #3 (Hold) at present.
Investors interested in the Zacks Business Services sector may look at some better-ranked stocks like Accolade ACCD, Amadeus IT Group AMADY and Affirm AFRM, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Accolade has a long-term earnings growth expectation of 11.4%. APP delivered a trailing four-quarter earnings surprise of 27.2%, on average.
Amadeus IT Group has a long-term earnings growth expectation of 8.6%. AMADY delivered a trailing four-quarter earnings surprise of 7%, on average.
Affirm has a long-term earnings growth expectation of 37%. AFRM delivered a trailing four-quarter earnings surprise of 17.8%, on average.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
TransUnion (TRU) : Free Stock Analysis Report
Amadeus IT Group SA Unsponsored ADR (AMADY) : Free Stock Analysis Report
Accolade, Inc. (ACCD) : Free Stock Analysis Report
Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。